Attikon Hospital clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   Neuromodulation Auditory System to Optimize Patient Experience…Neuromodulation Auditory System to Optimize Patient Experience During Dysfunctional Dialysis Access Endovascular Procedures

   Trial completed

   Also in this update: Study completion date changed from estimate of Mar 30, 2026 to Jan 1, 2026

   Attikon Hospital·Not applicable· NCT07467642· Registry history of NCT07467642 on ClinicalTrials.gov (opens the registry)

   Updated Sep 30, 2026

2. Minor

   Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4…Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function · Type 2 Diabetes Mellitus and Albuminuria

   Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting

   Attikon Hospital·Not applicable· NCT06611904· Registry history of NCT06611904 on ClinicalTrials.gov (opens the registry)

   Changed Oct 4, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.